Amid the pandemic transmission of COVID-19, every industry vertical is engaged in finding transformative ways of working that are resilient, purpose-driven, and adaptable.Patient connect is critical as they are psychologically down with the uncertainties and fear of transmission. The challenge is to engage and keep them informed, compliant, and motivated.
New ways of report and record-keeping are required to ensure data security and integrity.
Staying resilient and being prepared for such biothreats in the future requires a complete recoding of the clinical studies along with the corresponding regulatory guidelines. This means that pharmaceutical companies will need to get on board this adaptive culture to ramp up their networking, collaboration, data exchange, and cybersecurity capabilities.